Literature DB >> 1468837

The 1988-1989 measles epidemic in Hungary: assessment of vaccine failure.

M M Agócs1, L E Markowitz, I Straub, I Dömök.   

Abstract

Hungary has had a successful measles vaccination programme, achieving over 93% coverage in targeted groups. However, from September 1988 until December 1989, 17,938 measles cases were reported among the civilian population (attack rate [AR] = 169 per 100,000 population) with the majority of cases occurring in vaccinated people. National surveillance data were analysed to determine reasons for the outbreak and risk factors for vaccine failure. People born during 1971 and 1972 had been targeted for vaccination during campaigns in April and September of 1973 and had the highest AR (1332 and 1632 per 100,000, respectively). Epidemiological studies of vaccine efficacy conducted among secondary school students corroborated these findings. Among 754 secondary school students, those vaccinated during the April 1973 campaign were at highest risk compared with those vaccinated at routine health care after 1974 (relative risk = 10.9, 95% confidence interval [Cl]: 2.5-47.9). Among 341 primary school students, one-dose recipients were at higher risk compared with two-dose recipients controlling for age at and time elapsed since vaccination (P = 0.04).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1468837     DOI: 10.1093/ije/21.5.1007

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  8 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

2.  Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles.

Authors:  S Ratnam; G Tipples; C Head; M Fauvel; M Fearon; B J Ward
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

3.  Dynamic Features of Herd Immunity: Similarities in Age-Specific Anti-Measles Seroprevalence Data between Two Countries of Different Epidemiological History.

Authors:  Katalin Böröcz; Senka Samardžić; Ines Drenjančević; Ákos Markovics; Tímea Berki; Péter Németh
Journal:  J Clin Med       Date:  2022-02-21       Impact factor: 4.241

4.  Epidemiology of measles in Taiwan: dynamics of transmission and timeliness of reporting during an epidemic in 1988-9.

Authors:  M S Lee; C C King; C J Chen; S Y Yang; M S Ho
Journal:  Epidemiol Infect       Date:  1995-04       Impact factor: 2.451

5.  Development of an enzyme-linked immunosorbent assay for immunoglobulin M antibodies against measles virus.

Authors:  F Roodbari; M H Roustai; A Mostafaie; H Soleimanjdahi; R Sarrami Foroshani; F Sabahi
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

6.  Application of a fast and cost-effective 'three-in-one' MMR ELISA as a tool for surveying anti-MMR humoral immunity: the Hungarian experience.

Authors:  K Böröcz; Z Csizmadia; Á Markovics; N Farkas; J Najbauer; T Berki; P Németh
Journal:  Epidemiol Infect       Date:  2020-02-04       Impact factor: 2.451

7.  Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.

Authors:  Sara Carazo; Marie-Noëlle Billard; Amélie Boutin; Gaston De Serres
Journal:  BMC Infect Dis       Date:  2020-03-29       Impact factor: 3.090

8.  Relationship between natural and infection-induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA.

Authors:  K Böröcz; D Simon; S Erdő-Bonyár; K T Kovács; É Tuba; L Czirják; P Németh; T Berki
Journal:  Clin Exp Immunol       Date:  2020-10-13       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.